Your browser doesn't support javascript.
loading
The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century.
Caini, Saverio; Kusznierz, Gabriela; Garate, Verònica Vera; Wangchuk, Sonam; Thapa, Binay; de Paula Júnior, Francisco José; Ferreira de Almeida, Walquiria Aparecida; Njouom, Richard; Fasce, Rodrigo A; Bustos, Patricia; Feng, Luzhao; Peng, Zhibin; Araya, Jenny Lara; Bruno, Alfredo; de Mora, Doménica; Barahona de Gámez, Mónica Jeannette; Pebody, Richard; Zambon, Maria; Higueros, Rocio; Rivera, Rudevelinda; Kosasih, Herman; Castrucci, Maria Rita; Bella, Antonino; Kadjo, Hervé A; Daouda, Coulibaly; Makusheva, Ainash; Bessonova, Olga; Chaves, Sandra S; Emukule, Gideon O; Heraud, Jean-Michel; Razanajatovo, Norosoa H; Barakat, Amal; El Falaki, Fatima; Meijer, Adam; Donker, Gé A; Huang, Q Sue; Wood, Tim; Balmaseda, Angel; Palekar, Rakhee; Arévalo, Brechla Moreno; Rodrigues, Ana Paula; Guiomar, Raquel; Lee, Vernon Jian Ming; Ang, Li Wei; Cohen, Cheryl; Treurnicht, Florette; Mironenko, Alla; Holubka, Olha; Bresee, Joseph; Brammer, Lynnette.
Afiliação
  • Caini S; Netherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands.
  • Kusznierz G; National Institute of Respiratory Diseases "Emilio Coni", Santa Fe, Argentina.
  • Garate VV; National Institute of Respiratory Diseases "Emilio Coni", Santa Fe, Argentina.
  • Wangchuk S; Royal Centre for Disease Control, Department of Public Health, Ministry of Health, Thimphu, Bhutan.
  • Thapa B; Royal Centre for Disease Control, Department of Public Health, Ministry of Health, Thimphu, Bhutan.
  • de Paula Júnior FJ; Ministry of Health, Department of Surveillance of Transmissible Diseases, Brasília/DF, Brazil.
  • Ferreira de Almeida WA; Ministry of Health, Department of Surveillance of Transmissible Diseases, Brasília/DF, Brazil.
  • Njouom R; Virology Department, Centre Pasteur of Cameroon, Yaoundé, Cameroon.
  • Fasce RA; Sub-Department of Viral Diseases, Instituto de Salud Pública de Chile, Santiago, Chile.
  • Bustos P; Sub-Department of Viral Diseases, Instituto de Salud Pública de Chile, Santiago, Chile.
  • Feng L; Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, P.R. China.
  • Peng Z; Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, P.R. China.
  • Araya JL; National Influenza Center, Ministry of Health, San José, Costa Rica.
  • Bruno A; National Institute of Public Health Research (INSPI), National Reference Centre for Influenza and Other Respiratory Viruses, Guayaquil, Ecuador.
  • de Mora D; Agricultural University of Ecuador, Guayaquil, Ecuador.
  • Barahona de Gámez MJ; National Institute of Public Health Research (INSPI), National Reference Centre for Influenza and Other Respiratory Viruses, Guayaquil, Ecuador.
  • Pebody R; National Influenza Center, Ministry of Health, San Salvador, El Salvador.
  • Zambon M; Public Health England, London, England, United Kingdom.
  • Higueros R; Public Health England, London, England, United Kingdom.
  • Rivera R; National Influenza Center, Ministry of Health, Guatemala City, Guatemala.
  • Kosasih H; National Influenza Center, Ministry of Health, Tegucigalpa, Honduras.
  • Castrucci MR; US Naval Medical Research Unit No.2, Jakarta, Indonesia.
  • Bella A; National Influenza Center, Department of Infectious Diseases, National Institute of Health, Rome, Italy.
  • Kadjo HA; Department of Infectious Diseases, National Institute of Health, Rome, Italy.
  • Daouda C; Department of Epidemic Virus, Institut Pasteur, Abidjan, Côte d'Ivoire.
  • Makusheva A; Service of Epidemiological Diseases Surveillance, National Institute of Public Hygiene, Abidjan, Côte d'Ivoire.
  • Bessonova O; National Center of Expertise, Committee of Public Health Protection, Ministry of Health, Astana, Kazakhstan.
  • Chaves SS; National Center of Expertise, Committee of Public Health Protection, Ministry of Health, Uralsk City, Kazakhstan.
  • Emukule GO; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Heraud JM; Influenza Program, Centers for Disease Control and Prevention, Nairobi, Kenya.
  • Razanajatovo NH; Influenza Program, Centers for Disease Control and Prevention, Nairobi, Kenya.
  • Barakat A; National Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • El Falaki F; National Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Meijer A; National Influenza Center, Institut National d'Hygiène, Ministry of Health, Rabat, Morocco.
  • Donker GA; National Influenza Center, Institut National d'Hygiène, Ministry of Health, Rabat, Morocco.
  • Huang QS; National Institute for Public Health and the Environment, Centre for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, Bilthoven, The Netherlands.
  • Wood T; Netherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands.
  • Balmaseda A; Institute of Environmental Science and Research, Weillngton, New Zealand.
  • Palekar R; Institute of Environmental Science and Research, Weillngton, New Zealand.
  • Arévalo BM; National Influenza Center, Ministry of Health, Managua, Nicaragua.
  • Rodrigues AP; Pan American Health Organization, Washington, District of Columbia, United States of America.
  • Guiomar R; National Influenza Center, IC Gorgas, Panama City, Panama.
  • Lee VJM; Department of epidemiology, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Ang LW; National Influenza Reference Laboratory, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Cohen C; Public Health Group, Ministry of Health, Singapore, Singapore.
  • Treurnicht F; Public Health Group, Ministry of Health, Singapore, Singapore.
  • Mironenko A; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Holubka O; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Bresee J; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Brammer L; L.V.Gromashevsky Institute of Epidemiology and Infectious Diseases, National Academy of Medical Science of Ukraine, Department of Respiratory and other Viral Infections, Kyiv, Ukraine.
PLoS One ; 14(9): e0222381, 2019.
Article em En | MEDLINE | ID: mdl-31513690
ABSTRACT
We describe the epidemiological characteristics, pattern of circulation, and geographical distribution of influenza B viruses and its lineages using data from the Global Influenza B Study. We included over 1.8 million influenza cases occurred in thirty-one countries during 2000-2018. We calculated the proportion of cases caused by influenza B and its lineages; determined the timing of influenza A and B epidemics; compared the age distribution of B/Victoria and B/Yamagata cases; and evaluated the frequency of lineage-level mismatch for the trivalent vaccine. The median proportion of influenza cases caused by influenza B virus was 23.4%, with a tendency (borderline statistical significance, p = 0.060) to be higher in tropical vs. temperate countries. Influenza B was the dominant virus type in about one every seven seasons. In temperate countries, influenza B epidemics occurred on average three weeks later than influenza A epidemics; no consistent pattern emerged in the tropics. The two B lineages caused a comparable proportion of influenza B cases globally, however the B/Yamagata was more frequent in temperate countries, and the B/Victoria in the tropics (p = 0.048). B/Yamagata patients were significantly older than B/Victoria patients in almost all countries. A lineage-level vaccine mismatch was observed in over 40% of seasons in temperate countries and in 30% of seasons in the tropics. The type B virus caused a substantial proportion of influenza infections globally in the 21st century, and its two virus lineages differed in terms of age and geographical distribution of patients. These findings will help inform health policy decisions aiming to reduce disease burden associated with seasonal influenza.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza B / Influenza Humana Tipo de estudo: Prognostic_studies / Screening_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza B / Influenza Humana Tipo de estudo: Prognostic_studies / Screening_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article